Because the constitutively active tyrosine kinase product BCR‐ABL provided a pathogenetic explanation for the initiation of Ph+ ALL as well as a critical molecular therapeutic target, we further detected the expression levels of Pin 1 and BCR‐ABL and explored the potential relationship between these two proteins in ph+ ALL patients. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.